Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
569.5 DKK | +0.62% | -3.47% | +22.79% |
Apr. 22 | U.S. Futures, European Stocks Rise | DJ |
Apr. 16 | GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments | MT |
Sales 2024 * | 22.01B 3.16B | Sales 2025 * | 22.96B 3.3B | Capitalization | 30.54B 4.38B |
---|---|---|---|---|---|
Net income 2024 * | 1.28B 183M | Net income 2025 * | 1.34B 193M | EV / Sales 2024 * | 1.17 x |
Net cash position 2024 * | 4.82B 691M | Net cash position 2025 * | 3.75B 538M | EV / Sales 2025 * | 1.17 x |
P/E ratio 2024 * |
24
x | P/E ratio 2025 * |
22.8
x | Employees | 4,449 |
Yield 2024 * |
-
| Yield 2025 * |
0.62% | Free-Float | 99.68% |
Latest transcript on NKT A/S
1 day | +0.62% | ||
1 week | -3.47% | ||
Current month | -0.09% | ||
1 month | -3.23% | ||
3 months | +18.79% | ||
6 months | +66.81% | ||
Current year | +22.79% |
Managers | Title | Age | Since |
---|---|---|---|
Claes Westerlind
CEO | Chief Executive Officer | 42 | 16-12-31 |
Michael Hjorth
CEO | Chief Executive Officer | 58 | 04-12-31 |
Line Fandrup
DFI | Director of Finance/CFO | 44 | 20-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jens Due Olsen
CHM | Chairman | 60 | 05-12-31 |
Director/Board Member | 69 | 15-12-31 | |
Andreas Nauen
BRD | Director/Board Member | 59 | 16-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 773 M€ | -.--% | - | |
0.02% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 569.5 | +0.62% | 119,517 |
24-04-23 | 566 | -0.70% | 126,010 |
24-04-22 | 570 | -4.20% | 246,731 |
24-04-19 | 595 | -0.50% | 135,154 |
24-04-18 | 598 | +1.36% | 80,615 |
Delayed Quote Nasdaq Copenhagen, April 24, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.79% | 4.35B | |
+2.78% | 147B | |
+32.38% | 125B | |
+12.63% | 62.76B | |
+8.08% | 41.58B | |
-11.25% | 31.67B | |
+3.58% | 30.92B | |
+76.08% | 30.24B | |
+4.08% | 26.99B | |
+21.39% | 25.04B |
- Stock Market
- Equities
- NKT Stock